SEC Company Response from ELITE PHARMACEUTICALS (ELTP) — Feb 4, 2016
ELITE PHARMACEUTICALS INC /NV/ (ELTP) (CIK 0001053369)
Date: Feb. 4, 2016 · CIK: 0001053369 · Accession: 0001144204-16-079057
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-15697
Letter
Securities and Exchange Commission Filed June 15, 2015 Form 10-Q/A for the Quarterly Period Ended September 30, 2015 Filed December 30, File No. 001-15697
Re: Elite Pharmaceuticals, Inc.
Dear Mr. Rosenberg:
Elite Pharmaceuticals, Inc. hereby acknowledges receipt of the January 21, 2016 SEC Comment Letter regarding the above referenced periodic reports (the “Letter”).
We are very close to responding to the comments in the Letter. However, we are in the process of finalizing our Form 10-Q for the period ended December 31, 2015 so it can be timely filed within the next week. We anticipate responding to the comments in the Letter shortly after that.
Accordingly, we hereby request that our time to respond to the Letter be extended to February 19, 2016, 20 business days after the date of the Letter. At this time, we anticipate that we will be able to respond to the Letter on or before the requested extension date.
If you have any questions or comments or are unable to so extend our time to respond, please contact the undersigned at the above address.
Very truly yours,
/s/ Carter Ward
Show Raw Text
CORRESP 1 filename1.htm February 4, 2016 Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Attn: Jim B. Rosenberg Re: Elite Pharmaceuticals, Inc. Form 10-K for the Fiscal Year Ended March 31, 2015 Filed June 15, 2015 Form 10-Q/A for the Quarterly Period Ended September 30, 2015 Filed December 30, 2015 File No. 001-15697 Dear Mr. Rosenberg: Elite Pharmaceuticals, Inc. hereby acknowledges receipt of the January 21, 2016 SEC Comment Letter regarding the above referenced periodic reports (the “Letter”). We are very close to responding to the comments in the Letter. However, we are in the process of finalizing our Form 10-Q for the period ended December 31, 2015 so it can be timely filed within the next week. We anticipate responding to the comments in the Letter shortly after that. Accordingly, we hereby request that our time to respond to the Letter be extended to February 19, 2016, 20 business days after the date of the Letter. At this time, we anticipate that we will be able to respond to the Letter on or before the requested extension date. If you have any questions or comments or are unable to so extend our time to respond, please contact the undersigned at the above address. Very truly yours, /s/ Carter Ward Carter Ward, CFO